VICTORIS
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
HomeAuthorMoneycontrol news

Moneycontrol News

Moneycontrol News

Moneycontrol News

WBHIRA: Deviation from key provisions of RERA may dilute ground-level effectiveness of Act

REAL-ESTATE

WBHIRA: Deviation from key provisions of RERA may dilute ground-level effectiveness of Act

Experts have cited two major dilutions in key provisions of the RERA in HIRA, which was notified on June 1

Buy Divi’s Laboratories, target Rs 1210: Aditya Agarwal

BUSINESS

Buy Divi’s Laboratories, target Rs 1210: Aditya Agarwal

"We believe the stock is likely to resume its uptrend and therefore advice traders to buy this stock in a range of Rs 1080 to Rs 1070 with a price target of Rs 1210," says Aditya Agarwal of Way2Wealth Brokers.

Reliance Nivesh Lakshya Fund, an open-ended debt fund to be launched on June 18

BUSINESS

Reliance Nivesh Lakshya Fund, an open-ended debt fund to be launched on June 18

This scheme aims to capture the prevailing long-term yields by investing in 25 to 30 years Government Securities (G-Sec) for attaining long-term goals for investors.

Investec reiterates Buy on RBL Bank, ups target to Rs 660 on increased profit estimates

BUSINESS

Investec reiterates Buy on RBL Bank, ups target to Rs 660 on increased profit estimates

Investec feels the visibility on return on assets (RoA) improvement is high on a 2-year timeframe.

Buy Chennai Petroleum, target Rs 262: Aditya Agarwal

BUSINESS

Buy Chennai Petroleum, target Rs 262: Aditya Agarwal

"we recommend traders to go short in a range of Rs 307 to Rs 310 with a price target of Rs 262 and Stop loss placed above Rs 325," says Aditya Agarwal of Way2Wealth Brokers.

20 states agree to implement NHPS, 4 abstain

INDIA

20 states agree to implement NHPS, 4 abstain

The Odisha government has launched its own health assistance scheme, called Biju Swasthya Kalyan Yojana.

HDFC available at attractive valuation, can see 20% upside: CLSA

BUSINESS

HDFC available at attractive valuation, can see 20% upside: CLSA

CLSA has maintained Buy call on HDFC with a target price at Rs 2,200 per share, saying the housing finance company is among top picks in the sector.

Tourism ministry might not put up Taj Mahal for 'adoption' soon: Report

INDIA

Tourism ministry might not put up Taj Mahal for 'adoption' soon: Report

The 'Adopt a Heritage' initiative was launched by the tourism ministry in September 2017. The plan invites corporates to take over maintenance and operations of monuments.

Shujaat Bukhari and jawan's deaths postpone decision on extending Ramzan ceasefire

POLITICS

Shujaat Bukhari and jawan's deaths postpone decision on extending Ramzan ceasefire

The Centre had declared a conditional unilateral ceasefire in Jammu and Kashmir in order to facilitate peace-loving Muslims to observe Ramzan in a peaceful environment

Avenue Supermarts down nearly 3%; Citi maintains sell with target Rs 1,255

BUSINESS

Avenue Supermarts down nearly 3%; Citi maintains sell with target Rs 1,255

According to Citi, DMart’s e-commerce still miniscule and investments could continue. It has maintained sell call with a target of Rs 1,255.

UPL gains 3% after Deutsche Bank reiterates buy call with a target of Rs 890

BUSINESS

UPL gains 3% after Deutsche Bank reiterates buy call with a target of Rs 890

The global investment bank is betting on cross currency movements being favourable for the company so far.

Deutsche Bank attributes slowdown in realty stocks to new accounting standards

BUSINESS

Deutsche Bank attributes slowdown in realty stocks to new accounting standards

The brokerage house has a hold rating on DLF, while it has a buy call on Godrej Properties and Oberoi Realty.

Kotak Institutional Equities bets on Sadbhav Eng, Dilip Buildcon

BUSINESS

Kotak Institutional Equities bets on Sadbhav Eng, Dilip Buildcon

Brokerage house bets on the companies on the back of good track record of execution scale-up.

Motilal Oswal AMC is betting on these 2 spaces, should you?

BUSINESS

Motilal Oswal AMC is betting on these 2 spaces, should you?

Manish Sonthalia of Motilal Oswal AMC cites regulatory approvals as well as reduction in price erosion in the US as reasons for the upmove in pharma stocks

Alembic Pharma gains 7% on EIR from USFDA for formulation facility at Panelav

BUSINESS

Alembic Pharma gains 7% on EIR from USFDA for formulation facility at Panelav

The inspection by USFDA was carried out at formulation facility during the period from March 12 to March 20, 2018.

CM Kejriwal’s wife calls LG Baijal 'insecure' after she was refused entry into Raj Niwas

POLITICS

CM Kejriwal’s wife calls LG Baijal 'insecure' after she was refused entry into Raj Niwas

Sunita Kejriwal had gone with Kejriwal’s mother and wives of Deputy CM Manish Sisodia and PWD minister Satyendra Jain to meet the AAP ministers who have been staging a sit-in at the LG’s residence

Xiaomi Mijia's launches a new gimbal for smartphones in the Chinese market

BUSINESS

Xiaomi Mijia's launches a new gimbal for smartphones in the Chinese market

The new gimbal can fit handsets up to 86 mm wide and 200 g in weight and can supply up to 5V/1.5A power to them from its 5,000 mAh battery.

Prestige Estates stock rises 5% after CLSA retains Buy, sees 44% upside

BUSINESS

Prestige Estates stock rises 5% after CLSA retains Buy, sees 44% upside

CLSA sees large scale-up potential in residential & office business and likes company's platform-led strategy to growth.

Transcorp Int’l locked in 5% upper circuit ahead of Board meet to consider bonus issue

BUSINESS

Transcorp Int’l locked in 5% upper circuit ahead of Board meet to consider bonus issue

The company’s Board will be meeting June 21, 2018 for the purpose of allotment of 6356549 Equity shares of the company as bonus shares at par in proportion of 1 (one) such new Equity share for every 4 (four) existing equity share, the company said in a filing to the exchanges.

Dr Reddy’s Labs gains 3% on US FDA approval to anti-addiction drug

BUSINESS

Dr Reddy’s Labs gains 3% on US FDA approval to anti-addiction drug

Buprenorphine and naloxone are used to treat adults with opioid addiction.

Buy or sell: Top stock trading ideas by market experts which are good short term bets

BUSINESS

Buy or sell: Top stock trading ideas by market experts which are good short term bets

Rajesh Agarwal of AUM Capital recommends buying Hexaware Technologies with stop loss at Rs 441 and target of Rs 459, Adani Enterprises with stop loss at Rs 128 and target of Rs 142 and Punjab National Bank with stop loss at Rs 89 and target of Rs 96.

Closing Bell: Sensex recovers in late trade to end flat; TCS, Infosys lead

BUSINESS

Closing Bell: Sensex recovers in late trade to end flat; TCS, Infosys lead

Asian markets are cautiously mixed ahead of expected US tariffs.

Nervousness persist, Nifty may face resistance at 10,850 levels

BUSINESS

Nervousness persist, Nifty may face resistance at 10,850 levels

“The Nifty ended the session with a Hanging Man candle, which implies that nervousness still persists” says Jaydeb Dey of Stewart & Mackertich Wealth Management

Podcast | Stock Picks of the Day: 3 buy & sell ideas that could return 11-17%

BUSINESS

Podcast | Stock Picks of the Day: 3 buy & sell ideas that could return 11-17%

"10,929 will act as strong resistance and only a weekly close above this level will negate the bearish candle. On the flip side, 10,710 will act as immediate support, followed by 10,620," says Aditya Agarwal of Way2Wealth Brokers.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347